Market Eyes LiveModerna, Inc. (MRNA) Stock Rating
MELANY's data-driven read on Moderna, Inc. · Biological Products, (No Diagnostic Substances).
—
Live rating in app
···
Live price
Moderna is a commercial-stage biotech founded in 2010 that went public in December 2018. Its mRNA technology was validated by its covid vaccine, authorized in the US in December 2020. As of August 2025 the company had 35 mRNA candidates in clinical studies, spanning infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Entry zone, stop-loss, price targets, and live alerts unlock when you sign up. No card required.